Page de couverture de Pharma

Pharma

Greed, Lies, and the Poisoning of America

 Aperçu
En profiter Essayer pour 0,00 $
L'offre prend fin de 29 janvier 2026 à 23 h 59, HP.
Vos 3 premiers mois d'Audible à seulement 0,99 $/mois
1 nouveauté ou titre populaire à choisir chaque mois – ce titre vous appartiendra.
L'écoute illimitée des milliers de livres audio, de balados et de titres originaux inclus.
L'abonnement se renouvelle automatiquement au tarif de 0,99 $/mois pendant 3 mois, et au tarif de 14,95 $/mois ensuite. Annulation possible à tout moment.
Choisissez 1 livre audio par mois dans notre incomparable catalogue.
Écoutez à volonté des milliers de livres audio, de livres originaux et de balados.
L'abonnement Premium Plus se renouvelle automatiquement au tarif de 14,95 $/mois + taxes applicables après 30 jours. Annulation possible à tout moment.

Pharma

Auteur(s): Gerald Posner
Narrateur(s): Jacques Roy
En profiter Essayer pour 0,00 $

14,95 $/mois après 3 mois. L'offre prend fin de 29 janvier 2026 à 23 h 59, HP. Annulation possible à tout moment.

14,95$ par mois après 30 jours. Annulable en tout temps.

Acheter pour 34,99 $

Acheter pour 34,99 $

À propos de cet audio

 Award-winning journalist and New York Times bestselling author Gerald Posner reveals the heroes and villains of the trillion-dollar-a-year pharmaceutical industry and delivers “a withering and encyclopedic indictment of a drug industry that often seems to prioritize profits over patients” (The New York Times Book Review).

Pharmaceutical breakthroughs such as anti­biotics and vaccines rank among some of the greatest advancements in human history. Yet exorbitant prices for life-saving drugs, safety recalls affecting tens of millions of Americans, and soaring rates of addiction and overdose on pre­scription opioids have caused many to lose faith in drug companies. Now, Americans are demanding a national reckoning with a monolithic industry.

“Gerald’s dogged reporting, sets Pharma apart from all books on this subject” (The Washington Standard) as we are introduced to brilliant scientists, incorruptible government regulators, and brave whistleblowers facing off against company exec­utives often blinded by greed. A business that profits from treating ills can create far deadlier problems than it cures. Addictive products are part of the industry’s DNA, from the days when corner drugstores sold morphine, heroin, and cocaine, to the past two decades of dangerously overprescribed opioids.

Pharma also uncovers the real story of the Sacklers, the family that became one of America’s wealthiest from the success of OxyContin, their blockbuster narcotic painkiller at the center of the opioid crisis. Relying on thousands of pages of government and corporate archives, dozens of hours of interviews with insiders, and previously classified FBI files, Posner exposes the secrets of the Sacklers’ rise to power—revelations that have long been buried under a byzantine web of interlocking companies with ever-changing names and hidden owners. The unexpected twists and turns of the Sackler family saga are told against the startling chronicle of a powerful industry that sits at the intersection of public health and profits. “Explosively, even addictively, readable” (Booklist, starred review), Pharma reveals how and why American drug com­panies have put earnings ahead of patients. Sciences sociales Inspirant Santé Médecine Gouvernement Santé mentale Toxicomanie

Ce que les critiques en disent

"Jacques Roy's consistently clear performance of Posner's audiobook is appropriate for its tone. Posner's research into the pharmaceutical industry is unsparing. Listeners are guided through the history of an industry that routinely seeks profit over public interest. Key details are covered: Why are there so many variants to over-the-counter painkillers? How did Oxycontin become so popular despite demonstrable public harm? Posner's research is exhaustive and provides damning insights. ('Pharma bro' Martin Shkreli was publicly vilified in 2015 for raising a vital drug's cost from $13 from $750, but that price remains unchanged.) Roy's approach to this work provides a neutral yet engaging tone for its information on the nature of this controversial industry."
Pas encore de commentaire